Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2003

Study Completion Date

June 30, 2006

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

RADIATION

yttrium Y 90 ibritumomab tiuxetan

Trial Locations (87)

34

Instituto de Enfermedades Neoplasicas, Lima

2145

Westmead Hospital, Westmead

10010

Veterans Affairs Medical Center - New York, New York

10016

NYU Cancer Institute at New York University Medical Center, New York

10461

Albert Einstein Cancer Center at Albert Einstein College of Medicine, The Bronx

10466

MBCCOP-Our Lady of Mercy Cancer Center, The Bronx

11209

Veterans Affairs Medical Center - Brooklyn, Brooklyn

15236

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

15240

Veterans Affairs Medical Center - Pittsburgh, Pittsburgh

19096

CCOP - MainLine Health, Wynnewood

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

19713

CCOP - Christiana Care Health Services, Newark

20060

MBCCOP - Howard University Cancer Center, Washington D.C.

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

30322

Winship Cancer Institute of Emory University, Atlanta

33125

Veterans Affairs Medical Center - Miami, Miami

33612

Veterans Affairs Medical Center - Tampa (Haley), Tampa

43206

CCOP - Columbus, Columbus

44109

MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

46202

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis

46601

CCOP - Northern Indiana CR Consortium, South Bend

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

50309

John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines

50314

Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines

51040

Burgess Health Center, Onawa

53295

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee

53705

Veterans Affairs Medical Center - Madison, Madison

54301

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

54449

CCOP - Marshfield Clinic Research Foundation, Marshfield

55416

CCOP - Metro-Minnesota, Saint Louis Park

55455

University of Minnesota Cancer Center, Minneapolis

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

58122

CCOP - Merit Care Hospital, Fargo

60201

CCOP - Evanston, Evanston

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

61801

CCOP - Carle Cancer Center, Urbana

62526

CCOP - Central Illinois, Decatur

67218

Veterans Affairs Medical Center - Wichita, Wichita

68105

Veterans Affairs Medical Center - Omaha, Omaha

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

70112

MBCCOP - LSU Health Sciences Center, New Orleans

70121

CCOP - Ochsner, New Orleans

74136

CCOP - Oklahoma, Tulsa

76508

CCOP - Scott and White Hospital, Temple

80224

CCOP - Colorado Cancer Research Program, Incorporated, Denver

87131

MBCCOP - University of New Mexico HSC, Albuquerque

89106

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas

35294-3300

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

94304-1290

Veterans Affairs Medical Center - Palo Alto, Palo Alto

94305-5216

Stanford Cancer Center at Stanford University Medical Center, Stanford

32608-1197

Veterans Affairs Medical Center - Gainesville, Gainesville

33612-9497

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa

60611-4494

Veterans Affairs Medical Center - Lakeside Chicago, Chicago

61615-7828

CCOP - Illinois Oncology Research Association, Peoria

61104-2315

Swedish-American Regional Cancer Center, Rockford

46202-5289

Indiana University Cancer Center, Indianapolis

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

50316-2301

John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines

67214-3882

CCOP - Wichita, Wichita

02111

Cancer Center at Tufts - New England Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

49007-3731

CCOP - Kalamazoo, Kalamazoo

55417-2399

Veterans Affairs Medical Center - Minneapolis, Minneapolis

68128-4157

Midlands Cancer Center at Midlands Community Hospital, Papillion

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

07018

Veterans Affairs Medical Center - East Orange, East Orange

07601

CCOP - Northern New Jersey, Hackensack

08903

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

43623-3456

CCOP - Toledo Community Hospital, Toledo

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

19102-1192

Hahnemann University Hospital, Philadelphia

19111-2497

Fox Chase Cancer Center, Philadelphia

37212-2637

Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville

37232-6307

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville

53792-0001

University of Wisconsin Comprehensive Cancer Center, Madison

53226-3596

Medical College of Wisconsin Cancer Center, Milwaukee

00921-3201

MBCCOP - San Juan, San Juan

00927-5800

Veterans Affairs Medical Center - San Juan, San Juan

00936-7344

San Juan City Hospital, San Juan

0001

Pretoria Academic Hospital, Pretoria

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00070447 - Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma | Biotech Hunter | Biotech Hunter